Literature DB >> 21638027

Dual role of insulin-like growth factor-1 in acetyl-CoA carboxylase-alpha activity in human colon cancer cells HCT-8: downregulating its expression and phosphorylation.

Di-Xian Luo1, Xu-hong Peng, Yan Xiong, Duan-Fang Liao, Deliang Cao, Longjiang Li.   

Abstract

Insulin-like growth factor-1 (IGF-1) plays the role in cellular lipid synthesis and cell proliferation. However, the role of IGF-1 on the growth of colon cancer cell line HCT-8 is not clear. In this study, HCT-8 cells were exposed to IGF-1 at 0, 10, 50, or 100 ng/ml in serum-free medium. Fatty acid/lipid synthesis in HCT-8 cells was examined by 2-14C-acetate incorporation. HCT-8 cell growth and proliferation were determined by MTT assay and Trypan blue exclusive viable cell counting. We found that in serum starvation conditions, IGF-1 at 10-100 ng/ml induced dose-dependent down regulation of both the ACCα expression and the phosphorylation in HCT-8 cells, maintaining a balance in ACCα activity and lipid synthesis. IGF-1 reduced p-ATM, p-AMPK, and then p-ACCα protein levels in HCT-8 cells. IGF-1 increased p-Akt levels, but decreased p-ERK1/2 levels, leading to the decrease in ACCα protein and mRNA levels. Similarly, ERK1/2 inhibitor PD98059 reduced ACCα expression. IGF-1 influences neither HCT-8 cell growth nor their p53 protein levels and PARP cleavage. In a word, IGF-1 reduced ACCα phosphorylation via an ATM/AMPK signaling pathway and suppressed ACCα expression through an ERK1/2 transduction, playing a dual role in regulating ACCα activity and lipogenesis. This may render a cell with survival advantages under a serum starvation crisis, representing a novel mitogenic role of IGF-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21638027     DOI: 10.1007/s11010-011-0896-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  54 in total

1.  Fatty acid oxidation in human skeletal muscle.

Authors:  Michael D Jensen
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.

Authors:  Michael Milyavsky; Olga I Gan; Magan Trottier; Martin Komosa; Ofer Tabach; Faiyaz Notta; Eric Lechman; Karin G Hermans; Kolja Eppert; Zhanna Konovalova; Olga Ornatsky; Eytan Domany; M Stephen Meyn; John E Dick
Journal:  Cell Stem Cell       Date:  2010-07-08       Impact factor: 24.633

3.  Troglitazone stimulates acetyl-CoA carboxylase activity through a post-translational mechanism.

Authors:  G K Thampy; M J Haas; A D Mooradian
Journal:  Life Sci       Date:  2000-12-29       Impact factor: 5.037

4.  Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation.

Authors:  Saleh Adi; Bassam Bin-Abbas; Nan-Yan Wu; Stephen M Rosenthal
Journal:  Endocrinology       Date:  2002-02       Impact factor: 4.736

5.  Essential role of acetyl-CoA carboxylase in the glucose-induced insulin secretion in a pancreatic beta-cell line.

Authors:  S Zhang; K H Kim
Journal:  Cell Signal       Date:  1998-01       Impact factor: 4.315

6.  IGF-1 receptor signaling pathways and effects of AMPK activation on IGF-1-induced progesterone secretion in hen granulosa cells.

Authors:  Lucie Tosca; Christine Chabrolle; Sabine Crochet; Sophie Tesseraud; Joëlle Dupont
Journal:  Domest Anim Endocrinol       Date:  2007-04-09       Impact factor: 2.290

Review 7.  Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling - roles of p53, p73 and HIPK2.

Authors:  Nadja Bitomsky; Thomas G Hofmann
Journal:  FEBS J       Date:  2009-09-29       Impact factor: 5.542

8.  IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.

Authors:  Olivia Bibollet-Bahena; Guillermina Almazan
Journal:  J Neurochem       Date:  2009-03-28       Impact factor: 5.372

9.  AMPK activation inhibits the expression of HIF-1alpha induced by insulin and IGF-1.

Authors:  Caroline Treins; Joseph Murdaca; Emmanuel Van Obberghen; Sophie Giorgetti-Peraldi
Journal:  Biochem Biophys Res Commun       Date:  2006-02-24       Impact factor: 3.575

10.  Switching p53-dependent growth arrest to apoptosis via the inhibition of DNA damage-activated kinases.

Authors:  Pavla Hublarova; Kristina Greplova; Jitka Holcakova; Borivoj Vojtesek; Roman Hrstka
Journal:  Cell Mol Biol Lett       Date:  2010-06-04       Impact factor: 5.787

View more
  6 in total

1.  Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.

Authors:  Ga Bin Park; Daejin Kim
Journal:  Mol Cell Biochem       Date:  2017-08-17       Impact factor: 3.396

2.  Dysregulated lipid metabolism in cancer.

Authors:  Feng Zhang; Guangwei Du
Journal:  World J Biol Chem       Date:  2012-08-26

Review 3.  Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.

Authors:  Ji Cheng; Tao Zhang; Hongbin Ji; Kaixiong Tao; Jianping Guo; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-09-25

4.  Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines.

Authors:  Moses Koobotse; Jeff Holly; Claire Perks
Journal:  Oncotarget       Date:  2018-09-11

Review 5.  A New Twist in Protein Kinase B/Akt Signaling: Role of Altered Cancer Cell Metabolism in Akt-Mediated Therapy Resistance.

Authors:  Isabell Götting; Verena Jendrossek; Johann Matschke
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

6.  Glucose Concentration in Cell Culture Medium Influences the BRCA1-Mediated Regulation of the Lipogenic Action of IGF-I in Breast Cancer Cells.

Authors:  Moses O Koobotse; Dayane Schmidt; Jeff M P Holly; Claire M Perks
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.